Groundbreaking new test 90% accurate in finding patients at high risk of bowel cancer
Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...
Ibj.com21h
Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Jewish Press22h
Targeted mRNA Therapy Holds Promise for Crohn’s Disease, Colitis, and Beyond
The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.
Pharm Exec1d
Treating Disruptive Symptom’s in Crohn’s Patients: Q&A with Mark Genovese, MD
Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...
Crohn’s Disease Pipeline Insights, FDA Approvals, Drugs, Companies Report | DelveInsight
The leading Crohn's Disease companies such as Janssen, RedHill Biopharma, Amgen, Pfizer, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Abbvie, Mesoblast, Alfasigma, ...
Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
Health on MSN4d
My First Signs of Crohn's Disease Weren't Digestion-Related: What To Look Out For
Fact checked by Nick Blackmer Crohn's disease can cause symptoms unrelated to your digestion. Health's Crohn's Disease ...
The American Journal of Managed Care5d
FDA Approves Mirikizumab for Crohn Disease
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...